{"disease":{"id":"interstitial-lung-disease-due-to-systemic-disease-disorder","name":"interstitial lung disease due to systemic disease disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06758947","title":"Use of Selective JAK Inhibitor in ILD and Skin Tightness of Systemic Sclerosis Versus MMF","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07061873","title":"Physical Exercise Program for Adults With Diffuse Interstitial Lung Disease in a Pulmonary Rehabilitation Context","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":29,"lead_sponsor_name":"Universidad de La Frontera","has_results":false},{"nct_id":"NCT04311567","title":"Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Vastra Gotaland Region","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}